Multi-center Study to Validate niPGT-A

CompletedOBSERVATIONAL
Enrollment

2,586

Participants

Timeline

Start Date

April 27, 2018

Primary Completion Date

December 19, 2022

Study Completion Date

February 10, 2023

Conditions
AneuploidyChromosome AbnormalityInfertility
Interventions
DIAGNOSTIC_TEST

PGT-A

PGT-A will be carried out following the usual clinical practice: Trophectoderm biopsy samples from blastocysts are analyzed by NGS to screen for numerical chromosomal abnormalities.

DIAGNOSTIC_TEST

niPGT-A

Non-invasive preimplantation genetic test for embryo aneuploidy analyzing the spent culture media where the embryo is incubated up to the time of vitrification. This media contains traces of embryonic cell-free DNA (cfDNA) that can represent the genetic load of the embryo.

Trial Locations (10)

15036

Inmater - Clínica de Fertilidad, Lima

22203

Dominion Fertility, Arlington

28036

ProcreaTec, Madrid

92130

San Diego Fertility Center, San Diego

02109

Boston IVF Fertility Clinic, Boston

C1425DGQ

Pregna Medicina Reproductiva, Buenos Aires

91330-002

Nilo Frantz - Centro de Reprodução Humana, Boa Vista

00197

Genera Rome, Rome

05120

NASCERE, Mexico City

07720

Bahçeci Group, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Igenomix

INDUSTRY

NCT03520933 - Multi-center Study to Validate niPGT-A | Biotech Hunter | Biotech Hunter